MolNFT v1 · #146968 · protein
CU(II)-bound structure of the engineered cyt CB562 variant, CH3
6DYD · Soluble cytochrome B562: “CU(II)-bound structure of the engineered cyt CB562 variant, CH3”. X-ray diffraction, 3 ligands (HEC, CA, CU), 3 pockets (best druggability 0.66). MolNFT v1 #146968 on GenesisL1: 3D structure, binding sites…
- PDB
- 6DYD
- Type
- protein
- Length
- 212 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Soluble cytochrome B562
- UniProt
- P0ABE7
- Ligands
- HEC, CA, CU
- Pockets
- 3 · best druggability 0.66
Structure
x-ray diffraction · 1 distinct chain · 78% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, C | Soluble cytochrome B562 | protein | 106 | 78% helix, 0% strand | P0ABE7 |
Ligands and binding sites
- HEC · Heme C · ligand · 2 copies · chains A, C
- CA · Calcium ion · metal · 5 copies · chains A, C
- CU · Copper (II) ion · metal · chains A, C
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 201 | 0.66 | 0.85 | 31 | HEC |
| 2 | 262 | 0.59 | 0.79 | 28 | empty |
| 3 | 155 | 0.57 | 0.82 | 23 | HEC |
Interfaces
1 interface between chains.
- A–C · 508 Ų buried · 7 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 4 cofactor, 1 disulfide (heme c attachment, disulfide).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P0ABE7
- Elsewhere: RCSB PDB 6DYD · PDBe 6DYD · UniProt P0ABE7
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.